Revolution Medicines, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
AMRNAmarin Corp. Plc -3.36%13.241.6%$121.82m
JAZZJazz Pharmaceuticals Plc -3.75%96.962.3%$94.15m
PRGOPerrigo Co. Plc -1.05%46.056.8%$90.44m
VRXValeant Pharmaceuticals International, Inc. -6.28%14.4714.1%$85.14m
CTLTCatalent, Inc. -3.05%48.892.2%$71.98m
UTHRUnited Therapeutics Corp. -0.76%91.3214.3%$70.23m
AXSMAxsome Therapeutics, Inc. -0.43%63.271.9%$69.87m
ICLRICON plc -1.27%135.044.2%$65.46m
GWPHGW Pharmaceuticals Plc -0.94%85.756.2%$60.20m
HZNPHorizon Therapeutics Plc -3.06%27.536.5%$56.91m
SAGESAGE Therapeutics, Inc. 1.78%31.508.6%$47.67m
ICPTIntercept Pharmaceuticals, Inc. -3.89%65.0716.8%$45.40m
ZGNXZogenix, Inc. -1.27%23.369.2%$36.34m
PBHPrestige Consumer Healthcare, Inc. 3.22%36.284.0%$31.61m
PCRXPacira Biosciences, Inc. -2.19%31.7310.4%$31.20m

Company Profile

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.